High-throughput flow cytometry-based assay to identify apoptosis-inducing proteins

Mamatha Sauermann1, Florian Hahne, Christian Schmidt

  • 1Division of Molecular Genome Analysis, German Cancer Research Centre, Heidelberg, Germany.

Insights

Researchers developed a high-throughput flow cytometry assay to screen for proteins that trigger apoptosis (programmed cell death). This method successfully identified 6 novel apoptosis-inducing proteins from a pool of 200 candidates.

Area of Science:

  • Proteomics
  • Cell Biology
  • Biotechnology

Background:

  • The completion of the human genome sequence necessitates functional characterization of encoded proteins.
  • Understanding protein function is crucial for identifying disease-related mechanisms.

Purpose of the Study:

  • To develop and apply a high-throughput screening assay for identifying apoptosis-activating proteins.
  • To systematically analyze protein functions and their relation to diseases.

Main Methods:

  • A flow cytometry-based assay was developed to detect activated caspase-3 in cells overexpressing yellow fluorescent protein-tagged proteins.
  • High-throughput screening was performed using a flow cytometer with an autosampler.
  • Candidate proteins were validated using a microscopy-based nuclear fragmentation assay.

Main Results:

  • A pilot screen of 200 proteins was conducted.
  • The assay successfully identified proteins that induce apoptosis.
  • Six novel apoptosis inducers were identified and validated.

Conclusions:

  • The developed flow cytometry assay is effective for high-throughput screening of apoptosis-inducing proteins.
  • This method facilitates the systematic functional analysis of proteins encoded by the human genome.
  • The identified apoptosis inducers warrant further investigation for their roles in disease.